https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-to-Highlight-Clinical-Data-for-IW-3718-in-Persistent-Gastroesophageal-Reflux-Disease-GERD-at-Digestive-Disease-Week-2018/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- May 23, 2018